Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been formally diagnosed with Idiopathic Parkinson's Disease using a specific set of established diagnostic guidelines (known as the UK Parkinson's Disease Society Brain Bank Diagnostic Criteria).
- People whose Parkinson's Disease is rated between stage 1 and stage 3 on a standard scale used to measure how far the condition has progressed (called the Hoehn & Yahr Scale), including the in-between stages 1.5 and 2.5.
Who may not be able to join:
- People who have been diagnosed with a neurological condition other than Parkinson's Disease.
- People who have been diagnosed with a heart, lung, or metabolic condition (such as diabetes) or any other health condition that means physical exercise is not medically safe for them.
- People who have had a significant worsening of their condition or a hospital stay in the three months before the study assessments begin, or during the treatment period.
- People who have received a course of steroid medication — either by injection into a vein or taken by mouth — in the six months before the study begins, or during the treatment period.
- People who have significant difficulties with memory or thinking (specifically, a score below 21 on a standard cognitive test called the Montreal Cognitive Assessment), or who have language difficulties that would make it hard to understand or follow exercise instructions.
- People who have taken part in a structured, personalised strength training or aerobic exercise program in the three months before enrolling in the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mario González Iglesias, Physiotherapy, Universidad Rey Juan Carlos
Phone: +34 622113365
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Consent rate; Recruitment rate; Adherence rate; Intervention completion rate; Trial completion rate; Proportion of adverse events; Treatment-decision rate; Change in Theoretical Framework Acceptability Questionnaire; Client Satisfaction Questionnaire (CSQ-8); Average Rating of Perceived Exertion (RPE) during Resistance Training; Average Rating of Perceived Exertion (RPE) during Cardiorespiratory Exercise
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.